We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBRX icon
101
Forte Biosciences
FBRX
$1.57B
$1.2M 0.01%
+72,418
New +$1.61M
OKLO
102
Oklo
OKLO
$8.42B
$1.02M ﹤0.01%
98,300
– –
SAGE
103
DELISTED
Sage Therapeutics
SAGE
$881K ﹤0.01%
+42,800
New +$1.24M
SMC
104
Summit Midstream
SMC
$419M
$806K ﹤0.01%
58,214
– –
EDU icon
105
New Oriental
EDU
$8.98B
$761K ﹤0.01%
13,000
– –
CYTK icon
106
Cytokinetics
CYTK
$10.4B
$641K ﹤0.01%
21,772
– –
LU icon
107
Lufax Holding
LU
$1.3B
$636K ﹤0.01%
150,000
-4,837,455
-97% -$26.8M
MDGL icon
108
Madrigal Pharmaceuticals
MDGL
$11.8B
$485K ﹤0.01%
3,319
– –
GRND.WS
109
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$427K ﹤0.01%
540,000
– –
BNTX icon
110
BioNTech
BNTX
$23.5B
$418K ﹤0.01%
3,844
– –
KRTX
111
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$372K ﹤0.01%
2,200
– –
ALNY icon
112
Alnylam Pharmaceuticals
ALNY
$29.3B
$354K ﹤0.01%
2,000
– –
LUNRW
113
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$265K ﹤0.01%
950,000
– –
HIMS icon
114
Hims & Hers Health
HIMS
$7.31B
$264K ﹤0.01%
+42,000
New +$312K
KRYS icon
115
Krystal Biotech
KRYS
$9.66B
$232K ﹤0.01%
+2,000
New +$244K
CHE icon
116
Chemed
CHE
$7.22B
$208K ﹤0.01%
+400
New +$208K
HQY icon
117
HealthEquity
HQY
$8.75B
$205K ﹤0.01%
+2,800
New +$189K
AKRO
118
DELISTED
Akero Therapeutics
AKRO
$202K ﹤0.01%
+4,000
New +$186K
EHC icon
119
Encompass Health
EHC
$12.4B
$201K ﹤0.01%
3,000
-97,000
-97% -$6.67M
BPMC
120
DELISTED
Blueprint Medicines
BPMC
$201K ﹤0.01%
4,000
-18,420
-82% -$984K
FOLD
121
DELISTED
Amicus Therapeutics
FOLD
$195K ﹤0.01%
+16,000
New +$206K
RCM
122
DELISTED
R1 RCM Inc. Common Stock
RCM
$181K ﹤0.01%
12,000
-540,000
-98% -$9.08M
COGT icon
123
Cogent Biosciences
COGT
$7.24B
$166K ﹤0.01%
17,000
-966,452
-98% -$11.5M
AAC.WS
124
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$137K ﹤0.01%
200,000
– –
SEDA.WS
125
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$108K ﹤0.01%
866,250
– –
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Farallon Capital Management held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Farallon Capital Management deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Farallon Capital Management's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Farallon Capital Management added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Farallon Capital Management's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Farallon Capital Management fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Farallon Capital Management's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Farallon Capital Management opened 31 new positions and closed 37 in Q3 2023.
  • Farallon Capital Management's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.